Detalles de la búsqueda
1.
miR-9a minimizes the phenotypic impact of genomic diversity by buffering a transcription factor.
Cell
; 155(7): 1556-67, 2013 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24360277
2.
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Cancer
; 130(6): 936-946, 2024 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37962093
3.
Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer.
Oncologist
; 26(3): 208-214, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33230914
4.
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series.
J Natl Compr Canc Netw
; 18(7): 798-804, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32634770
5.
Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models.
J Vasc Interv Radiol
; 30(7): 1106-1115.e1, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30952520
6.
Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.
J Cancer Surviv
; 2024 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678525
7.
Metastatic pattern is a prognostic factor in BRAFV600E mutant colorectal cancer.
Cancer Treat Res Commun
; 35: 100714, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126990
8.
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors.
J Natl Cancer Inst
; 115(5): 578-585, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36762832
9.
Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
J Clin Oncol
; 41(2): 307-315, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126235
10.
Resilience in older adults with cancer: A scoping literature review.
J Geriatr Oncol
; 14(1): 101349, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35970715
11.
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
JTO Clin Res Rep
; 4(3): 100459, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36879929
12.
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial.
J Clin Oncol
; 41(2): 316-326, 2023 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36455189
13.
Targeting KRAS G12C-Mutated Advanced Colorectal Cancer: Research and Clinical Developments.
Onco Targets Ther
; 15: 747-756, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837349
14.
Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma.
Radiol Imaging Cancer
; 3(1): e200006, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575658
15.
Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients.
J Gastrointest Oncol
; 11(5): 952-963, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33209490
16.
Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies.
Cancers (Basel)
; 12(5)2020 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32384640
17.
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report.
Front Oncol
; 10: 581, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32373540
18.
Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAFV600E Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series.
Clin Colorectal Cancer
; 21(3): 267-271, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039233
19.
Clinical Trial Enrollment, Ineligibility, and Reasons for Decline in Older vs Younger Patients With Cancer in the National Cancer Institute Community Oncology Research Program.
JAMA Netw Open
; 5(10): e2235714, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215074
20.
Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib.
Clin Lung Cancer
; 22(6): e851-e855, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34059475
Resultados
1 -
20
de 20
1
Próxima >
>>